logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
T

Thomas Grinda

institut gustave roussy
H指数:10
被引数:511

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Clinical features associated with exceptional response on first-line anti-HER2-based therapy for metastatic breast cancer: real-world data from the ESME national cohort

与转移性乳腺癌一线抗HER2为基础治疗中表现出非凡疗效相关的临床特征：来自ESME国家队列的真实世界数据

Breast
IF7.9
2026-10-130
OA
Thomas Grinda; Matthieu Carton; Stefania Morganti; Audrey Mailliez; Christelle Levy; Thierry Petit; Thomas Bachelot; Monica Arnedos; Véronique Diéras; Vincent Massard; Florence Dalenc; Isabelle Desmoulins; Jean-Yves Pierga; Anthony Gonçalves; Caroline Bailleux; Jean-Sebastien Frenel; Lise Bosquet; Heather A. Parsons; William Jacot; Nancy U. Lin
TLSB-19 CENTRAL NERVOUS SYSTEM DISSEMINATION IN METASTATIC LOBULAR BREAST CANCER: A HISTOLOGY-BASED ANALYSIS

TLSB-19 弥漫性转移性小叶乳腺癌的中枢神经系统扩散：基于组织学的分析

Neuro-Oncology Advances
IF4.1
2026-08-070
OA
Guilherme Nader-Marta; Noah Graham; Anna Gorfinkel; Eliza Kallfelz; Celine Ibrahim; Catherine E Stever; Rebecca A Ottesen; Gregory Kirkner; Melinda Luo; Thomas Grinda; Craig Snow; Erica L Mayer; Sara M Tolaney; Nabihah Tayob; Sarah L Sammons; Jose Pablo Leone; Nancy U Lin
A Systematic Literature Review of the Effectiveness of CDK 4/6 Inhibitors for First-Line Treatment of HR+/HER2− Advanced/Metastatic Breast Cancer: A Comparison of Real-World Evidence

CDK 4/6抑制剂在HR+/HER2−晚期/转移性乳腺癌一线治疗中的有效性：真实世界证据的系统文献综述

Cancers
IF4.4
2026-07-230
OA
Timothy Pluard; Thomas Grinda; Rodrigo Dienstmann; Marc Thill; Beata Korytowsky; Connie Chen; Sofiya Portuhay; Elizabeth M. Salvo-Halloran; Imtiaz A. Samjoo; Nadia Harbeck
Characteristics and outcomes of patients with HER2-negative metastatic breast cancers with low expression of estrogen and progesterone receptors in the multicenter ESME cohort.

HER2阴性低表达雌激素和孕激素受体转移性乳腺癌患者的特征和结局：多中心ESME队列研究

The Breast
IF0
2026-05-180
OAAI
Marie Alexandre; Eva Teruel; Florence Dalenc; Thibaut de la Motte Rouge; Etienne Brain; Vincent Massard; Monica Arnedos; Audrey Mailliez; Jean-Marc Ferrero; Thomas Bachelot; Isabelle Desmoulins; Marie-Ange Mouret-Reynier; Christelle Levy; Antony Gonçalves; Anca Berghian; Thierry Petit; Jean-Sébastien Frenel; Anne-Laure Martin; Thomas Grinda; William Jacot
Comprehensive review of pregnancy associated breast cancer: clinical features, molecular characteristics and novel therapies

妊娠相关性乳腺癌的全面综述：临床特征、分子特征及新型疗法

European Journal of Cancer
IF7.1
2026-01-120
PRE
Alessandra Spata; Joana M. Ribeiro; Paolo Vigneri; Alberto Zambelli; Jean Zeghondy; Chayma Bousrih; Thomas Grinda; Alessandro Viansone; Alexandre J. Vivanti; Michaël Grynberg; Bruno Achutti Duso; Fabrice André; Barbara Pistilli; Elie Rassy
Genomic landscape of metastatic breast cancers in young adults: a liquid biopsy analysis of women aged 20-40 years

年轻成人转移性乳腺癌的基因组景观：一项对20-40岁女性进行的液体活检分析

The Breast
IF0
2026-01-020
OAAI
null Ernest Diab; Cyril Roussel-Simonin; Federica Giugliano; Julia Dixon-Douglas; Alessandra Spata; Martina Pagliuca; Lauriane Minot; Alexandre Xu-Vuillard; Fernanda Mosele; Thomas Grinda; Alessandro Viansone; Chayma Bousrih; Jean Zeghondy; Tarek Ben Ahmed; Claudio Nicotra; Arnaud Bayle; Antoine Italiano; Suzette Delaloge; Barbara Pistilli; Fabrice André
Recent treatment and survival trends in older versus younger women with HR-positive HER2-negative metastatic breast cancer in the real-life multicenter French ESME cohort

老年与年轻HR阳性HER2阴性转移性乳腺癌女性患者真实世界多中心法国ESME队列中的近期治疗与生存趋势

European Journal of Cancer
IF7.1
2025-12-050
PRE
Fanny Bouteiller; Sophie Gourgou; Michaël Bringuier; Angéline Galvin; Audrey Mailliez; Nicolas Bertrand; Mony Hung; Jean-Sébastien Frenel; Vincent Massard; Thomas Bachelot; Carole Plumio; Anthony Gonçalves; Christelle Levy; Lise Bosquet; William Jacot; Suzette Delaloge; Thomas Grinda; Carine Bellera
Survival outcomes and the role of DNADX ctDNA testing in patients treated with sacituzumab govitecan for metastatic breast cancer☆

生存结局及DNADX ctDNA检测在应用sacituzumab govitecan治疗转移性乳腺癌患者中的作用☆

ESMO Open
IF8.3
2025-09-300
OAAI
S. Morganti; R.J. Kusmick; M.E. Hughes; F. Brasó-Maristany; K. Smith; P. Tarantino; R. Vega-Leon; T. Grinda; F. Pardo; K. Dvir; G.L. Suggs; S. Buck; M. Skeffington; A.C. Garrido-Castro; H.A. Parsons; S.L. Sammons; A. Prat; N.U. Lin; S.M. Tolaney; A. Giordano
Real-world treatment patterns and effectiveness after disease progression on CDK4/6 inhibitors for HR-positive/HER2-negative metastatic breast cancer in the ESME-MBC cohort

CDK4/6抑制剂治疗后疾病进展的HR阳性/HER2阴性转移性乳腺癌患者中真实世界的治疗模式与疗效：ESME-MBC队列研究

ESMO Open
IF8.3
2025-09-170
PREAI
R. Varnier; D. Pérol; W. Jacot; A. Mailliez; V. Diéras; F. Dalenc; A. Gonçalves; C. Levy; M. Arnedos; J.-S. Frenel; C. Bailleux; V. Massard; E. Brain; B. Sauterey; A.-M. Savoye; L. Bosquet; J.-C. Thery; T. Petit; T. Bachelot; T. Grinda; I. Ray-Coquard
Outcomes of subsequent treatment regimens after trastuzumab deruxtecan in patients with metastatic breast cancer

曲妥珠单抗德鲁替康后转移性乳腺癌患者的后续治疗方案结果

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE
IF7.2
2025-09-012
PRE
Tarantino, Paolo; Lee, Do; Foldi, Julia; Soulos, Pamela R.; Gross, Cary P.; O'Meara, Tess; Grinda, Thomas; Morganti, Stefania; Waks, Adrienne G.; Winer, Eric P.; Lin, Nancy U.; Krop, Ian E.; Tolaney, Sara M.; Sammons, Sarah; Lustberg, Maryam
Outcomes with trastuzumab deruxtecan by biomarker status, line of treatment and prior receipt of sacituzumab govitecan in a large real-world database of patients with metastatic breast cancer

曲妥珠单抗德鲁替康（trastuzumab deruxtecan）在不同生物标志物状态、治疗线数以及之前是否接受过沙西妥珠单抗戈维替康（sacituzumab govitecan）治疗的患者中的疗效，基于一项大型真实世界数据库的转移性乳腺癌患者研究。

ESMO Open
IF8.3
2025-07-010
PRE
P. Tarantino; D. Lee; J. Foldi; P.R. Soulos; C.P. Gross; T. Grinda; E.P. Winer; N.U. Lin; I.E. Krop; S.M. Tolaney; M. Lustberg; S. Sammons

研究方向

暂未获取到该数据
B
Barbara Pistilli
H 指数:40论文数:337被引数:6,668
S
Suzette Delaloge
H 指数:88论文数:825被引数:3.6万
W
William Jacot
H 指数:51论文数:481被引数:1.7万
S
Sarah Sammons
H 指数:23论文数:210被引数:1,676
E
Elie Rassy
H 指数:37论文数:259被引数:4,467
T
Thomas Bachelot
H 指数:65论文数:556被引数:2.4万
A
Anthony Gonçalvès
H 指数:61论文数:729被引数:1.9万
A
Audrey Mailliez
H 指数:29论文数:236被引数:4,774
I
Isabelle Desmoulins
H 指数:24论文数:203被引数:4,006
J
Jean‐Sébastien Frenel
H 指数:38论文数:411被引数:8,210